HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is there a role for omacetaxine in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors?

AuthorsMoussab Damlaj, Sarit Assouline
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 56 Issue 1 Pg. 6-7 (Jan 2015) ISSN: 1029-2403 [Electronic] United States
PMID24898667 (Publication Type: Journal Article, Comment)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Harringtonines
Topics
  • Antineoplastic Agents, Phytogenic (therapeutic use)
  • Female
  • Harringtonines (therapeutic use)
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (drug therapy, pathology)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: